Use of benzydamine in the treatment of p40-dependent diseases

Details Use of benzydamine in the treatment of p40-dependent diseases Use of benzydamine in the treatment of p40-dependent diseases

A - Human Necessities

61

K

A61K 31/416 (2006.01)

Patent

CA 2760176

Use of benzydamine in the treatment of inflammatory diseases, in particular Crohn's disease, rheumatoid arthritis, psoriatic arthritis, and psoriasis, caused by an expression or overexpression of the cytokine subunit p40.

L'invention porte sur une utilisation de benzydamine dans le traitement de maladies inflammatoires, en particulier la maladie de Crohn, la polyarthrite rhumatoïde, l'arthrite psoriasique et le psoriasis, provoquées par une expression ou une surexpression de la sous-unité de cytokine p40.

Affiliated with

Also associated with

Rating

Use of benzydamine in the treatment of p40-dependent diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of benzydamine in the treatment of p40-dependent diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of benzydamine in the treatment of p40-dependent diseases will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1551391